Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
19 studies found for:    SAILS
Show Display Options
Rank Status Study
1 Recruiting Virtual Sailing Simulator in Individuals With Spinal Cord Injury
Condition: Spinal Cord Injury
Intervention: Device: The VSail-Access simulator
2 Recruiting Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort
Conditions: Sleep Apnea Hypopnea Syndrome;   COPD;   Emphysema;   Lung Cancer
Intervention: Other: poligraphy
3 Terminated
Has Results
Statins for Acutely Injured Lungs From Sepsis
Conditions: Sepsis;   Acute Lung Injury
Interventions: Drug: Rosuvastatin;   Drug: Placebo
4 Active, not recruiting Use of Shade in U.S. and Australian City Parks
Condition: Skin Cancer
Intervention: Behavioral: Shade Sail
5 Completed Evaluating Health Outcomes and QOL After ALI Among Participants of the ALTA, OMEGA, EDEN, and SAILS ARDS Network Trials
Condition: Respiratory Distress Syndrome, Adult
6 Completed Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Intervention: Drug: sirolimus and hydroxychloroquine
7 Not yet recruiting Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs
Conditions: Peripheral Arterial Disease;   Cardiovascular Diseases;   Vascular Diseases
Interventions: Drug: Allogeneic Mesenchymal Stromal Cell;   Other: Placebo
8 Not yet recruiting Study of Acarbose in Longevity
Condition: Aging
Interventions: Drug: Acarbose;   Other: Placebo
9 Recruiting Sleep Apnea in Lung Cancer: A Prospective Study
Conditions: Lung Cancer;   Sleep-Disordered Breathing
Intervention: Other: Sleep testing
10 Recruiting Sustained Aeration of Infant Lungs Trial
Conditions: Preterm Birth;   Extreme Prematurity
Interventions: Procedure: Sustained Inflation;   Procedure: Standard of Care
11 Terminated Study of Liraglutide in Individuals With Type 2 Diabetes Using Insulin
Condition: Type 2 Diabetes
Interventions: Drug: liraglutide;   Drug: placebo injection
12 Completed
Has Results
Safety of Intravenous Thrombolytics in Stroke on Awakening
Condition: Stroke
Intervention: Drug: tPA
13 Unknown 
Has Results
A Study of GSK1349572 Versus Raltegravir (RAL) With Investigator Selected Background Regimen in Antiretroviral-Experienced, Integrase Inhibitor-Naive Adults
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: GSK1349572;   Drug: Raltegravir;   Drug: GSK1349572 Placebo;   Drug: Raltegravir Placebo
14 Recruiting Safety and Efficacy Study of Conbercept in Diabetic Macular Edema (DME) (Sailing)
Condition: Diabetic Macular Edema
Interventions: Drug: Conbercept;   Other: Sham injection;   Procedure: Laser;   Other: Sham laser
15 Recruiting Evaluation and Characterization of Motion Sickness on Passengers Sailing on the Astrolabe
Condition: Sea Sickness
Intervention: Other: sea sickness questionnaires
16 Active, not recruiting A Study To Evaluate Ara-C and Idarubicin in Combination With the Selective Inhibitor Of Nuclear Export (SINE) Selinexor (KPT-330) in Patients With Relapsed Or Refractory AML
Condition: Acute Myeloid Leukemia (Relapsed/Refractory)
Interventions: Drug: Selinexor;   Drug: Idarubcin;   Drug: Cytarabine
17 Active, not recruiting Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment
Condition: Hepatitis C Virus
Interventions: Drug: Paritaprevir;   Drug: Ritonavir;   Drug: Dasabuvir;   Drug: Ombitasvir;   Drug: Ribavirin
18 Completed The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine
Condition: Headache
Interventions: Drug: Prochlorperazine;   Drug: Ketamine;   Drug: Diphenhydromine;   Drug: Ondansetron;   Drug: Normal Saline
19 Completed Cardiovascular Risk in General Practice in France: Cardiovascular Risk Week
Condition: Healthy

Study has passed its completion date and status has not been verified in more than two years.